<DOC>
	<DOCNO>NCT00735410</DOCNO>
	<brief_summary>Annual trial registration influenza vaccine strain composition season 2008/2009</brief_summary>
	<brief_title>Safety Immunogenicity Trivalent Split Influenza Vaccine Using Strain Composition 2008/2009</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>≥ 18 year age , mentally competent , willing able give inform consent prior study entry available visit schedule study able comply study requirement good health determine : medical history physical examination clinical judgment investigator They Have serious ( judgment investigator ) disease , include limited : Cancer , except localize skin cancer Advanced congestive heart failure Chronic obstructive pulmonary disease ( COPD ) Autoimmune disease ( include rheumatoid arthritis ) Acute progressive hepatic disease Acute progressive renal disease Severe neurological psychiatric disorder Severe Asthma They history anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine ( e.g. , ovalbumin , chicken protein , chicken feather , influenza viral protein neomycin polymyxin ) . Known suspected ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) result example : receipt immunosuppressive therapy ( parental oral cortical steroid cancer chemotherapy/radiotherapy ) within past 60 day full length study ; Receipt immunostimulants , Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within past 3 month full length study , Suspected know HIV infection HIVrelated disease . Known suspected history drug alcohol abuse . They bleed diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject ; Women pregnant woman childbearing potential unwilling practice acceptable contraception duration study ( 21 day ) . Influenza vaccination laboratory confirm influenza within last 6 month one influenza vaccination within past 12 month Within past 4 week receive : another vaccine investigational agent ; Any acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day . They experience fever ( i.e. , axillary temperature ≥ 38°C ) within last 3 day Simultaneous participation another clinical study . Any condition , , opinion investigator , might prevent subject participation interfere evaluation study objective . Severely obese Body Mass Index ( BMI ) &gt; 35 Site personnel involve evaluation safety immediate relative exclude participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>Seasonal</keyword>
	<keyword>Split</keyword>
</DOC>